Cargando…
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
The collection and clinical use of COVID-19 convalescent plasma (CCP) as a therapy for COVID-19 infection is under development and early use in many centers worldwide. We conducted an international survey of centers undertaking studies of CCP to provide understanding of the common themes and differe...
Autores principales: | Murphy, Michael, Estcourt, Lise, Grant-Casey, John, Dzik, Sunny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320682/ https://www.ncbi.nlm.nih.gov/pubmed/32703664 http://dx.doi.org/10.1016/j.tmrv.2020.06.003 |
Ejemplares similares
-
COVID-19 Convalescent Plasma: Now Is the Time for Better Science
por: Dzik, Sunny
Publicado: (2020) -
Convalescent Plasma for Covid-19 — Making Sense of the Inconsistencies
por: Estcourt, Lise, et al.
Publicado: (2022) -
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020) -
How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021) -
COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)